Lynda Chin
Directeur Général chez Apricity Health LLC
Profil
Lynda Chin is the founder of AVEO Pharmaceuticals, Inc. (founded in 2001) and Metamark Genetics, Inc. (founded in 2007).
At Metamark Genetics, she held the title of Director from 2007 to 2012.
She is also the founder of Apricity Health LLC.
Dr. Chin's former jobs include Chairman-Genomic Medicine Department at The University of Texas at Austin, Scientific Director at Dana-Farber Cancer Institute, Inc., Associate Member at The Broad Institute, Inc., Principal at Albert Einstein College of Medicine, Inc., and Professor at Harvard Medical School.
Dr. Chin received her doctorate degree from Albert Einstein College of Medicine, Inc. in 1993.
Postes actifs de Lynda Chin
| Sociétés | Poste | Début |
|---|---|---|
Apricity Health LLC
 Apricity Health LLC Miscellaneous Commercial ServicesCommercial Services Apricity Health LLC is a digital health company that aims to bridge the gap between academic specialty care and real-world practice. The company is based in Houston, TX. Apricity Health is committed to disseminating clinical expertise to benefit patients everywhere, especially those without access to subspecialty care. Apricity Health develops digital solutions to make novel life-saving cancer therapies safer, better, and more accessible to patients. The company was founded by world-renowned physician scientists in cancer and immuno-oncology, including Keith T. Flaherty, James Allison, Lynda Chin, and Padmanee Sharma. Lynda Chin has been the CEO since incorporation. | Directeur Général | - |
Anciens postes connus de Lynda Chin
| Sociétés | Poste | Fin |
|---|---|---|
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Fondateur | 31/12/2012 |
| The University of Texas at Austin | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Directeur Technique/Scientifique/R&D | - |
Formation de Lynda Chin
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Health Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
Apricity Health LLC
Apricity Health LLC Miscellaneous Commercial ServicesCommercial Services Apricity Health LLC is a digital health company that aims to bridge the gap between academic specialty care and real-world practice. The company is based in Houston, TX. Apricity Health is committed to disseminating clinical expertise to benefit patients everywhere, especially those without access to subspecialty care. Apricity Health develops digital solutions to make novel life-saving cancer therapies safer, better, and more accessible to patients. The company was founded by world-renowned physician scientists in cancer and immuno-oncology, including Keith T. Flaherty, James Allison, Lynda Chin, and Padmanee Sharma. Lynda Chin has been the CEO since incorporation. | Commercial Services |
